Profile
Dr. Hiroaki Serizawa is a Chief Executive Officer at AMD Therapeutics LLC.
Dr. Serizawa was previously employed as a President, Chief Executive Officer & Director by Coyote Pharmaceuticals, Inc., an Executive Director by Lifescience Catalyst Partners, Inc., an Assistant Professor by University of Kansas, a Principal by TNP Partners Corp., and a Chief Executive Officer by Tor USA, Inc.
Hiroaki Serizawa active positions
| Companies | Position | Start |
|---|
Former positions of Hiroaki Serizawa
| Companies | Position | End |
|---|---|---|
| Lifescience Catalyst Partners, Inc. | Director/Board Member | 31/12/2004 |
| University of Kansas | Corporate Officer/Principal | 31/12/2002 |
TNP Partners Corp.
 TNP Partners Corp. Investment ManagersFinance TNP Partners Corp (TNP) is an independent partner-owned firm located near Tokyo with a U.S. office in Sunnyvale, California. Formerly known as TSUNAMI Network Partners Corp., TNP was established in 2000 by government and private entities in Kanagawa on the west side of Tokyo. The firm seeks to attract venture companies as well as business support resources to the Kanagawa area and foster a Silicon Valley-like business community. They operate in close relationship with their asset management subsidiary TNP On The Road Corp., managing venture capital investment funds. | Corporate Officer/Principal | - |
| Tor USA, Inc. | Chief Executive Officer | - |
Coyote Pharmaceuticals, Inc.
 Coyote Pharmaceuticals, Inc. BiotechnologyHealth Technology Coyote Pharmaceuticals, Inc. operates a biopharmaceutical company. It focuses on creating high value therapeutics for large unmet medical needs in several therapeutic categories including neurodegenerative, cardiovascular, oncologic, and inflammatory diseases. The company was founded by Hiroaki Serizawa in 2009 and is headquartered in Menlo Park, CA. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Coyote Pharmaceuticals, Inc.
Coyote Pharmaceuticals, Inc. BiotechnologyHealth Technology Coyote Pharmaceuticals, Inc. operates a biopharmaceutical company. It focuses on creating high value therapeutics for large unmet medical needs in several therapeutic categories including neurodegenerative, cardiovascular, oncologic, and inflammatory diseases. The company was founded by Hiroaki Serizawa in 2009 and is headquartered in Menlo Park, CA. | Health Technology |
TNP Partners Corp.
TNP Partners Corp. Investment ManagersFinance TNP Partners Corp (TNP) is an independent partner-owned firm located near Tokyo with a U.S. office in Sunnyvale, California. Formerly known as TSUNAMI Network Partners Corp., TNP was established in 2000 by government and private entities in Kanagawa on the west side of Tokyo. The firm seeks to attract venture companies as well as business support resources to the Kanagawa area and foster a Silicon Valley-like business community. They operate in close relationship with their asset management subsidiary TNP On The Road Corp., managing venture capital investment funds. | Finance |
| Tor USA, Inc. | |
| Lifescience Catalyst Partners, Inc. |
- Stock Market
- Insiders
- Hiroaki Serizawa